Kedudukan dalam Saham
#31264
Q-linea AB (publ), founded in 2008 and based in Uppsala, Sweden, specializes in... Q-linea AB (publ), founded in 2008 and based in Uppsala, Sweden, specializes in developing diagnostic instruments and associated consumables for infection detection. The company crafts advanced in vitro diagnostic platforms, specifically engineered to identify infectious diseases. A key product is ASTar, an innovative system designed to rapidly assess antibiotic susceptibility in positive blood cultures. Q-linea's overarching mission is to deliver cutting-edge solutions to healthcare professionals.
Perubahan (1 tahun)
-62.23%
Perdagangan Q-linea AB (publ) (QLINEA)
Harga QLINEA dengan permodalan pasaran b
Modal pasaran bagi Q-linea AB (publ)(QLINEA)
Modal Pasaran: $13.95M
Sehingga August 2026, Q-linea AB (publ) mempunyai modal pasaran sebanyak $13.95M. Ini menjadikan Q-linea AB (publ) syarikat ke-31264th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Q-linea AB (publ) dari 2018 hingga 2026
QLINEA berbanding dengan 5 teratas yang paling popular stocks
| Harga QLINEA |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.460T
|
+39,145,811.15%
|
|
|
|
|
$4.489T
|
+32,186,794.62%
|
|
|
|
|
$4.141T
|
+29,687,594.15%
|
|
|
|
|
$3.569T
|
+25,584,135.96%
|
|
|
|
|
$2.798T
|
+20,060,083.18%
|
